Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.09 USD | -6.08% | -12.22% | +52.97% |
10/05 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
08/05 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.97% | 281M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Aquestive Therapeutics Files $250 Million Mixed Shelf